As of 2026-04-01, 甲磺酸艾立布林注射液's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 4.17%, above the industry average by 4.2 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (4.17%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 4 competitors in the same category, 甲磺酸艾立布林注射液's overall mention rate surpasses 4 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
甲磺酸艾立布林注射液's Mention Rate is 4.17%, lower than 0.6% of competitors
甲磺酸艾立布林注射液's First Mention is 0.00%, lower than 0.9% of competitors
甲磺酸艾立布林注射液's Preferred Rate is 0.00%, lower than 100.0% of competitors
甲磺酸艾立布林注射液's Positive Rate is 4.17%, lower than 8.9% of competitors
甲磺酸艾立布林注射液's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 甲甲磺酸艾立布林注射液 (Current Brand) | 4.17% | 0% | 0% | 4.17% | 0% | View Details |
| 康康复新液 | 0% | 0% | 0% | 0% | 0% | View Details |
| 小小柴胡颗粒 | 0% | 0% | 0% | 0% | 0% | View Details |
| 氨氨咖黄敏胶囊 | 0% | 0% | 0% | 0% | 0% | View Details |
| 骨骨痛灵酊 | 0% | 0% | 0% | 0% | 0% | View Details |
